Gabapentin Tablet
Product Images NDC 63629-8491

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63629-8491). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Image 01)

Line graph depicting mean pain scores over 8 weeks comparing placebo and Gabapentin, 3600 mg/day. The x-axis shows weeks from baseline to 8, and the y-axis represents mean pain scores from 0 to 10. The graph includes a 4-week dose titration period followed by a 4-week fixed dose period.*

FDA Label Image

Figure 2 (Image 02)

A line graph depicting mean pain score over 7 weeks during a study with 3-week dose titration and 4-week fixed dose periods. It compares placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day groups, showing pain scores on the vertical axis and weeks on the horizontal axis.*

FDA Label Image

Figure 3 (Image 03)

A bar chart titled 'Figure 3. Proportion of Responders (patients with ≥ 50% reduction in pain score) at Endpoint: Controlled PHN Studies' compares the percentage of responders in two studies. Study 1 shows 12% for placebo (PBO) and 29% for Gabapentin 3600 mg. Study 2 shows 14% for placebo, 32% for Gabapentin 1800 mg, and 34% for Gabapentin 2400 mg. Statistical significance is indicated with p-values less than 0.01 and 0.001.*

FDA Label Image

Image-04 (Image 04)

A formula for calculating creatinine clearance (CLCr) based on age, weight, serum creatinine, and a gender adjustment factor for female patients, shown as part of drug dosing considerations.*

FDA Label Image

Gabapentin Structural Formula (Image 05)

Chemical structure of gabapentin showing a cyclohexane ring attached to an amino methyl group and an acetic acid group.*

FDA Label Image

Image-09 (Image 09)

A scatter plot chart showing the percentage difference on the y-axis versus daily dose in mg on the x-axis for Gabapentin at doses of 600, 900, 1200, and 1800 mg. The chart compares results from three different studies labeled Study a, Study b, and Study c, with distinct markers for each study.*

FDA Label Image

Label (Lbl636298491)

Label for Gabapentin Tablets, USP 600 mg oral tablets by Bryant Ranch Prepack. The label displays the NDC 63629-8491-1, with a highlighted 600 mg strength. It includes storage instructions, manufacturer and relabeler information, barcode, and indicates a package size of 500 tablets for prescription use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.